慢性乙型肝炎纤维化胶囊研究  

A Study on the Effect of Ruangan Yin on Chronic Hepatitis B Fibrosis

作　　者：王倩嵘[1] 申玮[1] 蒋时红[2] 赵启运[1] 袁丽娜[1] 张振强[2] 

机构地区：[1]河南省疾病预防控制中心,郑州市450003 [2]河南中医学院,450008

出　　处：《医药论坛杂志》2004年第20期38-38,40,共2页Journal of Medical Forum

基　　金：河南省科技攻关课题 ( 0 2 2 3 0 3 3 2 0 0 )

摘　　要：目的　探讨慢性肝炎纤维化对慢性肝炎的影响。方法　对 4 0例用某胶囊治疗的慢性乙型肝炎病人及未用某胶囊的 30例对照病人治疗前后的血清标本进行血清PCⅢ、HA、LN水平的检测。结果　经某胶囊治疗后使治疗前升高的血清PCⅢ、HA、LM水平明显降低 ,且显著低于对照组 (P <0 0 5 ) ,从而证明某胶囊有降低血清PCⅢ、HA、LM水平 。Objective To discuss the effect of Ruangan Yin on hepatitis B fibrosis.Methods To test the level of PCⅢ,HA and LM in the blood serums specimen from 40 cases of hepatitis B treated by Ruangan Yin and 30 control cases of hepatitis B without being treated with the therapy before and after the treatment.Results Precollagenous fibers(PCⅢ),Hyaluronic Acid(HA)and Lamellar Mucin(LM) increased before treatment were dramatically decreased,especially compared with the control group(P< 0.05) after the application of the therapy,so it has proved Ruangan Yin has the effects of decreasing the level of PCⅢ,HA,LM and fibrosis of the liver.

关 键 词：胶囊 PCⅢ 慢性乙型肝炎 HA 纤维化 血清标本 治疗后 

分 类 号：R512[医药卫生—内科学] R575[医药卫生—临床医学]